Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

[ad_1] Company announcement – No. 34 / 2023 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark, September 14, 2023 – Zealand Pharma…

The obesity drugs waiting to hit the market

[ad_1] Novo Nordisk said a large study had shown its highly effective obesity drug Wegovy also had a clear cardiovascular benefit, boosting the Danish drugmaker’s hopes of moving beyond Wegovy’s…

Zealand Pharma Hosts Conference Call on May 11 at 2pm CET (8am ET) to Present First Quarter 2023 Results

[ad_1] Press Release– No. 3 / 2023 Zealand Pharma Hosts Conference Call on May 11 at 2pm CET (8am ET) to Present First Quarter 2023 Results Copenhagen, Denmark, May 4, 2023 – a…

Total number of shares and voting rights in Zealand Pharma at April 28, 2023

[ad_1] Company announcement – No. 18 / 2023 Total number of shares and voting rights in Zealand Pharma at April 28, 2023 Copenhagen, Denmark, April 28, 2023 – Zealand Pharma…

Zealand Pharma to Participate in 22nd Annual Needham Virtual Healthcare Conference

[ad_1] Press release – No. 2 / 2023 Zealand Pharma to Participate in 22nd Annual Needham Virtual Healthcare Conference Copenhagen, Denmark, April 12, 2023 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no.…

Zealand Pharma A/S publishes a listing prospectus regarding admission to trading and official listing of 6,578,948 new shares on Nasdaq Copenhagen

[ad_1] Company announcement – No. 13 / 2023 Zealand Pharma A/S publishes a listing prospectus regarding admission to trading and official listing of 6,578,948 new shares on Nasdaq Copenhagen NOT…

Zealand Pharma Provides Update on Silicon Valley Bank Closure

[ad_1] Company announcement – No. 6 / 2023 Zealand Pharma Provides Update on Silicon Valley Bank Closure Update to company announcement No.5 following joint statement by U.S. Treasury, Federal Reserve,…